Genetic diversity of hepatitis B virus genotypes B6, D and F among circumpolar indigenous individuals

Journal of Viral Hepatitis

Volumn 20, Issue 2, 2013, Pages 122-130

  Kowalec, K ^a,e   Minuk, G Y ^b   Borresen M L ^c   Koch, A ^c   McMahon, B J ^d   Simons, B ^d   Osiowy, C ^a,b  

^a Public Health Agency of Canada   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c STATENS SERUM INSTITUT   (Denmark)

^d Liver Disease and Hepatitis Program   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Arctic; hepatocellular carcinoma; Inuit; mutations; quasispecies

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLONAL EVOLUTION; FEMALE; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC CODE; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B VIRUS GENOTYPE B6; HEPATITIS B VIRUS GENOTYPE D; HEPATITIS B VIRUS GENOTYPE F; HUMAN; INDIGENOUS PEOPLE; MALE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; VIRUS CELL INTERACTION; VIRUS GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARCTIC REGIONS; CANADA; CHILD; DNA MUTATIONAL ANALYSIS; EVOLUTION, MOLECULAR; FEMALE; GENETIC VARIATION; GENOME, VIRAL; GENOTYPE; GREENLAND; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INUITS; MALE; MIDDLE AGED; PHYLOGENY; YOUNG ADULT;

EID: 84872140342     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2012.01632.x     Document Type: Article

References (36)

1. Tulisov A, McMahon BJ, Koch A, et al. Viral hepatitis in the Arctic. A review from a Circumpolar Workshop on Viral hepatitis, ICCH13. Alaska Med 2007; 49 (2 Suppl): 193-203.
2. Hurlburt KJ, McMahon BJ, Simonetti JP, et al. Hepatitis B-associated vasculitis in Alaska Natives: viral genotype, clinical and serologic outcome. Liver Int 2007; 27 (5): 627-632. (Pubitemid 47097312)
3. Helgason A, Palsson G, Pedersen HS, et al. mtDNA variation in Inuit populations of Greenland and Canada: migration history and population structure. Am J Phys Anthropol 2006; 130 (1): 123-134.
4. Liaw YF, Chu CM,. Hepatitis B virus infection. Lancet 2009; 373 (9663): 582-592.
5. Chotiyaputta W, Lok AS,. Hepatitis B virus variants. Nat Rev Gastroenterol Hepatol 2009; 6 (8): 453-462.
6. Krarup HB, Andersen S, Madsen PH, Okkels H, Hvingel BH, Laurberg P,. Benign course of long-standing hepatitis B virus infection among Greenland Inuit? Scand J Gastroenterol 2008; 43 (3): 334-343. (Pubitemid 351238365)
7. Sakamoto T, Tanaka Y, Simonetti J, et al. Classification of hepatitis B virus genotype B into 2 major types based on characterization of a novel subgenotype in Arctic indigenous populations. J Infect Dis 2007; 196 (10): 1487-1492. (Pubitemid 351411985)
8. Børresen ML, Koch A, Biggar RJ, et al. Hepatocellular carcinoma and other liver disease among greenlanders chronically infected with hepatitis B virus: a population-based study. J Natl Cancer Inst 2011; 103 (22): 1676-1685.
9. Livingston SE, Simonetti JP, McMahon BJ, et al. Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis 2007; 195 (1): 5-11. (Pubitemid 44958221)
10. Liu S, Zhang H, Gu C, et al. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst 2009; 101 (15): 1066-1082.
11. Ozasa A, Tanaka Y, Orito E, et al. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology 2006; 44 (2): 326-334. (Pubitemid 44214871)
12. Yin J, Xie J, Liu S, et al. Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma. Am J Gastroenterol 2011; 106 (1): 81-92.
13. Yang HI, Yeh SH, Chen PJ, et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 2008; 100 (16): 1134-1143.
14. Liu F, Chen L, Yu DM, et al. Evolutionary patterns of hepatitis B virus quasispecies under different selective pressures: correlation with antiviral efficacy. Gut 2011; 60 (9): 1269-1277.
15. Osiowy C,. Sensitive detection of HBsAg mutants by a gap ligase chain reaction assay. J Clin Microbiol 2002; 40 (7): 2566-2571. (Pubitemid 34747363)
16. Günther S, Li BC, Miska S, Kruger DH, Meisel H, Will H,. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 1995; 69 (9): 5437-5444.
17. Durantel D, Carrouée-Durantel S, Werle-Lapostolle B, et al. A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus. Hepatology 2004; 40 (4): 855-864. (Pubitemid 39288118)
18. Takahashi K, Aoyama K, Ohno N, et al. The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection. J Gen Virol 1995; 76 (Pt 12): 3159-3164. (Pubitemid 26003128)
19. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG,. The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 25 (24): 4876-4882.
20. Deng W, Maust BS, Nickle DC, et al. DIVEIN: a web server to analyze phylogenies, sequence divergence, diversity, and informative sites. Biotechniques 2010; 48 (5): 405-408.
21. Tamura K, Dudley J, Nei M, Kumar S,. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24 (8): 1596-1599. (Pubitemid 47236692)
22. Lin CL, Kao JH,. Clinical implications of hepatitis B virus variants. J Formos Med Assoc 2010; 109 (5): 321-325.
23. Langer BC, Frosner GG, von Brunn A,. Epidemiological study of viral hepatitis types A, B, C, D and E among Inuits in West Greenland. J Viral Hepat 1997; 4 (5): 339-349. (Pubitemid 127733424)
24. Yeung P, Wong DK, Lai CL, Fung J, Seto WK, Yuen MF,. Profile of pre-S deletions in the natural history of chronic hepatitis B infection. J Med Virol 2010; 82 (11): 1843-1849.
25. Minuk GY, Nicolle LE, Postl B, Waggoner JG, Hoofnagle JH,. Hepatitis virus infection in an isolated Canadian Inuit (Eskimo) population. J Med Virol 1982; 10 (4): 255-264. (Pubitemid 13217872)
26. McMahon BJ,. Natural history of chronic hepatitis B. Clin Liver Dis 2010; 14 (3): 381-396.
27. Milich D, Liang TJ,. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 2003; 38 (5): 1075-1086. (Pubitemid 37314815)
28. Wu S, Imazeki F, Kurbanov F, et al. Evolution of hepatitis B genotype C viral quasi-species during hepatitis B e antigen seroconversion. J Hepatol 2011; 54 (1): 19-25.
29. Chu CJ, Hussain M, Lok ASF,. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 2002; 122 (7): 1756-1762. (Pubitemid 34651418)
30. Wang HY, Chien MH, Huang HP, et al. Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases. J Virol 2010; 84 (7): 3454-3463.
31. Sardanyes J, Elena SF, Sole RV,. Simple quasispecies models for the survival-of-the-flattest effect: the role of space. J Theor Biol 2008; 250 (3): 560-568.
32. Forbi JC, Vaughan G, Purdy MA, et al. Epidemic history and evolutionary dynamics of hepatitis B virus infection in two remote communities in rural Nigeria. PLoS ONE 2010; 5 (7): e11615.
33. Zuniga MC,. A pox on thee! Manipulation of the host immune system by myxoma virus and implications for viral-host co-adaptation. Virus Res 2002; 88 (1-2): 17-33. (Pubitemid 35251898)
34. Iloeje UH, Yang HI, Chen CJ,. Natural history of chronic hepatitis B: what exactly has REVEAL Revealed? Liver Int 2012; doi:10.1111/ j.1478-3231.2012.02805.x.
35. Shamliyan TA, MacDonald R, Shaukat A, et al. Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference. Ann Intern Med 2009; 150 (2): 111-124.
36. Khudyakov Y,. Coevolution and HBV drug resistance. Antivir Ther 2010; 15 (3 Pt B): 505-515.